CS Medica is a Danish company active in medical technology. The company specializes in the development of new medical treatments. The portfolio includes medical cannabis (CBD) products, with the greatest focus on dietary supplements and various treatment care. The products are used, for example, by patients suffering from psoriasis, osteoarthritis, and hair loss. The largest operations are found in the Nordic market, where the products are resold under their own brand.

Quotes for CS MEDICA A/S

Right Now

+/-
-0.52
%
-9,00%
Latest
5.26
High
5.88
Low
5.16
Volume
6 699
Turnover (DKK)
36 204
Market Value (MDKK)
57,9
Time (Latest trade)

Board

CEO

  • Lone Henriksen

Chairperson of the Board

  • Jørgen Flemming Ladefoged

Board

  • Anders Permin
  • Bo Unéus
  • Gitte Lund Henriksen
  • Stein Løkstad

Largest Owners

Name Capital % Votes % Date
Lone Henriksen 36,69 36,69 2021-12-31
Gitte Henriksen 36,60 36,60 2022-05-20
Finn-Ove Henriksen and Nina Henriksen 3,34 3,34 2021-12-31
Ylber Rexhepi 2,32 2,32 2021-12-31
Tonoy Sayeed 1,46 1,46 2021-12-31
Kent Eklund 1,03 1,03 2021-12-31
Taulant Bara 1,03 1,03 2021-12-31
Diaz Capital Invest AB 0,91 0,91 2022-02-03
Thomas Gidlund 0,90 0,90 2021-12-31
Andreas Kjær 0,89 0,89 2021-12-31
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-08-19 Delårsrapport 2022-Q3

  • 2022-11-18 Bokslutskommuniké 2022